Shenfei Ma

机构：Tianjin People's Hospital, Second Hospital of Tianjin Medical University, Tianjin Medical University

发表论文 13 篇 · 总被引 316 次 · h-index 9

代表论文

• Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma (2022 · Frontiers in Genetics · 被引 106)
• AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer (2020 · Cancer Medicine · 被引 75)
• Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer (2022 · Frontiers in Oncology · 被引 32)
• Combination with vorinostat enhances the antitumor activity of cisplatin in castration‐resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH (2022 · The Prostate · 被引 22)
• MiR-96-5p induced NDRG1 deficiency promotes prostate cancer migration and invasion through regulating the NF-κB signaling pathway (2022 · Cancer Biomarkers · 被引 20)
• Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy (2020 · World Journal of Surgical Oncology · 被引 19)